EUVIMEDEUVIMED entdecken
Crossref

Incidence and risk factors for recurrent Clostridioides difficile infection in pediatric at-risk groups in selected Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) hospitals

Lucila Baldassarre iD, Caroline Quach-Thanh iD, Verinsa Mouajou Feujio, Fazia Tadount, Claudia Deyirmendjian, Marie-Astrid Lefebvre, Nisha Thampi, Oliver Schneider, Isabela Fabri-Karam, Shauna O'Donnell, James Okeny-Owere, N Audy und 1 weitere

Infection Control & Hospital Epidemiology · 2024

DOI: 10.1017/ice.2023.174 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Infection Control & Hospital Epidemiology, 2024. Verfasst von Lucila Baldassarre und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Infectious Disease, and Immunology, University of Montreal, Montreal, Québec, Canada. Hauptthemen laut MEDLINE: Clostridioides difficile, Clostridium Infections. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Incidence and risk factors for recurrent Clostridioides difficile infection (rCDI) are well established in adults, though data are lacking in pediatrics. We aimed to determine incidence of and risk factors for rCDI in pediatrics.

Methods

This retrospective cohort study of pediatric patients was conducted at 3 tertiary-care hospitals in Canada with laboratory-confirmed CDI between April 1, 2012, and March 31, 2017. rCDI was defined as an episode of CDI occurring 8 weeks or less from diagnostic test date of the primary episode. We used logistic regression to determine and quantify risk factors significantly associated with rCDI.

Results

In total, 286 patients were included in this study. The incidence proportion for rCDI was 12.9%. Among hospitalized patients, the incidence rate was estimated at 2.6 cases of rCDI per 1,000 hospital days at risk (95% confidence interval [CI], 1.7–3.9). Immunocompromised patients had higher incidence of rCDI (17.5%; P = .03) and higher odds of developing rCDI independently of antibiotic treatment given for the primary episode (odds ratio [OR], 2.31; 95% CI, 1.12–5.09). Treatment with vancomycin monotherapy did not show statistically significant protection from rCDI, independently of immunocompromised status (OR, 0.33; 95% CI, 0.05–1.15]).

Conclusions

The identification of increased risk of rCDI in immunocompromised pediatric patients warrants further research into alternative therapies, prophylaxis, and prevention strategies to prevent recurrent disease burden within these groups. Treatment of the initial episode with vancomycin did not show statistically significant protection from rCDI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Clostridioides difficileClostridium InfectionsAdultHumansChildVancomycinIncidenceRetrospective StudiesRecurrenceAnti-Bacterial AgentsRisk FactorsHospitals

Substanzen

VancomycinAnti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Microbiology, Infectious Disease, and Immunology, University of Montreal, Montreal, Québec, Canada.
  • Centre Hospitalier Universitaire Sainte Justine Research Centre, Montreal, Québec, Canada.
  • Division of Infectious Diseases, Department of Paediatrics, The Montreal Children's Hospital of the McGill University Health Centre, Montreal, Québec, Canada.
  • Children's Hospital of Eastern Ontario, Division of Infectious Diseases, Immunology and Allergy, Department of Pediatrics, Ottawa, Ontario, Canada.
  • Department of Family Medicine and Emergency Medicine, University of Montreal, Montreal, Québec, Canada.
  • Research Institute of the McGill University Health Centre, Montreal, Québec, Canada.

ORCID-Profile: Lucila Baldassarre, Caroline Quach-Thanh

Zitieren

APA

Baldassarre, L., Quach-Thanh, C., Mouajou Feujio, V., Tadount, F., Deyirmendjian, C., Lefebvre, M. A., Thampi, N., Schneider, O., Fabri-Karam, I., O'Donnell, S., Okeny-Owere, J., Audy, N., & Desmarais, N. (2024). Incidence and risk factors for recurrent Clostridioides difficile infection in pediatric at-risk groups in selected Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) hospitals. Infection Control & Hospital Epidemiology. https://doi.org/10.1017/ice.2023.174

Vancouver

Baldassarre L, Quach-Thanh C, Mouajou Feujio V, Tadount F, Deyirmendjian C, Lefebvre MA, et al. Incidence and risk factors for recurrent Clostridioides difficile infection in pediatric at-risk groups in selected Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) hospitals. Infection Control & Hospital Epidemiology. 2024. doi:10.1017/ice.2023.174

BibTeX
@article{Baldassarre2024,
  author = {Baldassarre, Lucila and Quach-Thanh, Caroline and Mouajou Feujio, Verinsa and Tadount, Fazia and Deyirmendjian, Claudia and Lefebvre, Marie-Astrid and Thampi, Nisha and Schneider, Oliver and Fabri-Karam, Isabela and O'Donnell, Shauna and Okeny-Owere, James and Audy, N and Desmarais, Nadia},
  title = {Incidence and risk factors for recurrent Clostridioides difficile infection in pediatric at-risk groups in selected Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) hospitals},
  journal = {Infection Control & Hospital Epidemiology},
  year = {2024},
  doi = {10.1017/ice.2023.174}
}
Kostenlos starten →